Scott D. Olson

university of texas system

H指数:33

被引数:7,086

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Autologous adipose-derived mesenchymal stromal cells for chronic traumatic brain injury

自体脂肪来源间充质基质细胞用于慢性创伤性脑损伤

Brain

IF11.7

2026-05-070

PRE

An assessment of green plasma: The in vitro hemostatic superiority of a currently discarded blood product

绿色血浆的评估：一种目前被废弃的血液制品在体外止血方面的优越性

Transfusion

IF2

2026-02-010

OAAI

Autograft Enlargement After the Ross Procedure in Pediatric Patients: Somatic Growth or Pathologic Dilatation?

Ross手术术后自体移植扩大：是躯体生长还是病理性扩张？

World Journal for Pediatric and Congenital Heart Surgery

IF1

2026-01-010

PRE

Developmental stage-dependent transcriptomic responses to neonatal intraventricular hemorrhage

发育阶段依赖性转录组反应对新生儿脑室内出血的响应

Journal of Neuroinflammation

IF10.1

2025-11-280

OAAI

Transcriptomic and histological characteristics of innate immune activation in brain parenchyma in a rat model of neonatal intraventricular hemorrhage

新生大鼠脑室内出血模型中脑实质固有免疫激活的转录组学和组学特征

Fluids and Barriers of the CNS

IF6.2

2025-07-031

Enhancing the safety and efficacy of cell therapy with programmed sense-and-respond function

通过编程的感知-响应功能增强细胞疗法的安全性与有效性

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2025-04-280

OAAI

Low molecular weight heparin decreases pro-coagulant activity in clinical MSC products

CYTOTHERAPY

IF3.2

2024-02-011

PRE

Autologous bone marrow mononuclear cells to treat severe traumatic brain injury in children

自体骨髓单个核细胞治疗儿童重型颅脑损伤

BRAIN

IF11.7

2024-01-054

PRE

Validation and characterization of a novel blood-brain barrier platform for investigating traumatic brain injury

用于研究创伤性脑损伤的新型血脑屏障平台的验证和表征

SCIENTIFIC REPORTS

IF3.9

2023-09-269

OAAI

Dexmedetomidine Alters the Inflammatory Profile of Rat Microglia In Vitro

右美托咪定在体外改变大鼠小胶质细胞的炎症分布

NEUROCRITICAL CARE

IF3.6

2022-11-234

An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody-Drug Conjugates

MOLECULAR CANCER THERAPEUTICS

IF5.5

2022-07-0621

Enhancing Mesenchymal Stromal Cell Potency: Inflammatory Licensing via Mechanotransduction

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-07-0612

OAAI

Time dependent analysis of rat microglial surface markers in traumatic brain injury reveals dynamics of distinct cell subpopulations

SCIENTIFIC REPORTS

IF3.9

2022-04-1514

OAAI

Determining Sex-Based Differences in Inflammatory Response in an Experimental Traumatic Brain Injury Model

在实验性创伤性脑损伤模型中确定基于性别的炎症反应差异

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-02-0913

OAAI

Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products

STEM CELLS TRANSLATIONAL MEDICINE

IF4.9

2022-02-0894

OAAI

First-in-Human Segmental Esophageal Reconstruction Using a Bioengineered Mesenchymal Stromal Cell-Seeded Implant

JTO CLINICAL AND RESEARCH REPORTS

IF3.5

2021-09-017

Combination therapy with Treg and mesenchymal stromal cells enhances potency and attenuation of inflammation after traumatic brain injury compared to monotherapy

Stem Cells

IF3.6

2020-12-3121

OAAI

High-resolution and differential analysis of rat microglial markers in traumatic brain injury: conventional flow cytometric and bioinformatics analysis

SCIENTIFIC REPORTS

IF3.9

2020-07-2029

OAAI

Wharton's Jelly for Augmented Cleft Palate Repair in a Rat Critical-Size Alveolar Bone Defect Model

TISSUE ENGINEERING PART A

IF2.9

2020-06-017

PREAI

Human cord blood-derived regulatory T-cell therapy modulates the central and peripheral immune response after traumatic brain injury

STEM CELLS TRANSLATIONAL MEDICINE

IF4.9

2020-05-0724

OAAI

Scott D. Olson

个人简介

教育背景

工作经历

荣誉奖项

研究方向